A Study of OSI-7904L as Treatment in Patients With Head and Neck Cancer Who Have Failed First-Line Therapy
This study has been completed.
Sponsor:
OSI Pharmaceuticals
Information provided by:
OSI Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00116909
First received: June 30, 2005
Last updated: March 13, 2007
Last verified: March 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | August 2005 |
| Estimated Primary Completion Date: | No date given |